ArticleFrontiers in immunology2025

Evaluating the triglyceride-glucose index as a biomarker for inflammatory bowel disease risk: insights from a UK Biobank prospective study.

Manli Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.